11-Mar-2025
No headlines found.
Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia
PRNewswire (Thu, 20-Feb 5:30 PM ET)
PRNewswire (Fri, 14-Feb 6:10 PM ET)
Aurora Cannabis Announces Supply Agreement with SNDL
PRNewswire (Thu, 6-Feb 8:50 PM ET)
Aurora Cannabis Announces Fiscal 2025 Third Quarter Results
PRNewswire (Wed, 5-Feb 7:00 AM ET)
PRNewswire (Thu, 23-Jan 7:00 AM ET)
Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call
PRNewswire (Wed, 22-Jan 5:02 PM ET)
Empowering the Next Generation: Aurora Announces German Internship Program
PRNewswire (Fri, 10-Jan 7:00 AM ET)
Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect
PRNewswire (Tue, 17-Dec 7:00 AM ET)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of March 11, 2025, ACB stock price declined to $4.33 with 760,418 million shares trading.
ACB has a beta of 1.32, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.03 to the broad based SPY ETF.
ACB has a market cap of $237.62 million. This is considered a Small Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $63 million in Revenue and $.41 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.37.
In the last 3 years, ACB traded as high as $45.60 and as low as $2.84.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ.
ACB has outperformed the market in the last year with a return of +36.2%, while the SPY ETF gained +10.0%. In the last 3 month period, ACB beat the market returning -0.9%, while SPY returned -7.5%. However, in the most recent 2 weeks ACB has underperformed the stock market by returning -22.8%, while SPY returned -6.9%.
ACB support price is $4.21 and resistance is $4.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB shares will trade within this expected range on the day.